CA2841880A1 - Methods and compositions for diagnosis and prognosis of renal injury and renal failure - Google Patents

Methods and compositions for diagnosis and prognosis of renal injury and renal failure Download PDF

Info

Publication number
CA2841880A1
CA2841880A1 CA2841880A CA2841880A CA2841880A1 CA 2841880 A1 CA2841880 A1 CA 2841880A1 CA 2841880 A CA2841880 A CA 2841880A CA 2841880 A CA2841880 A CA 2841880A CA 2841880 A1 CA2841880 A1 CA 2841880A1
Authority
CA
Canada
Prior art keywords
subject
hours
cohort
likelihood
step comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2841880A
Other languages
English (en)
French (fr)
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
James Patrick Kampf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astute Medical Inc
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of CA2841880A1 publication Critical patent/CA2841880A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA2841880A 2011-07-09 2012-07-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure Abandoned CA2841880A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161506038P 2011-07-09 2011-07-09
US61/506,038 2011-07-09
PCT/US2012/045583 WO2013009573A1 (en) 2011-07-09 2012-07-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (1)

Publication Number Publication Date
CA2841880A1 true CA2841880A1 (en) 2013-01-17

Family

ID=47506416

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2841880A Abandoned CA2841880A1 (en) 2011-07-09 2012-07-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Country Status (9)

Country Link
US (2) US20140171522A1 (cg-RX-API-DMAC10.html)
EP (1) EP2729803A4 (cg-RX-API-DMAC10.html)
JP (1) JP2014521088A (cg-RX-API-DMAC10.html)
CN (1) CN103858008B (cg-RX-API-DMAC10.html)
AU (1) AU2012282918A1 (cg-RX-API-DMAC10.html)
CA (1) CA2841880A1 (cg-RX-API-DMAC10.html)
EA (1) EA201490105A1 (cg-RX-API-DMAC10.html)
MX (1) MX2014000283A (cg-RX-API-DMAC10.html)
WO (1) WO2013009573A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150355181A1 (en) * 2013-01-25 2015-12-10 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for human epididymis protein-4 (he4)
WO2015081102A1 (en) 2013-11-27 2015-06-04 Gnubio, Inc. Microfluidic droplet packing
CN104045453B (zh) * 2014-06-11 2016-08-24 句容市鑫诚果业家庭农场 一种石榴专用有机肥料及其制备方法
EP3155086B1 (en) 2014-06-16 2021-10-20 Bio-Rad Laboratories, Inc. Size alternating injection into drops to facilitate sorting
CN104062294A (zh) * 2014-07-11 2014-09-24 青岛千士医疗科技有限公司 一种支气管/肺上皮细胞线粒体损伤的检测方法
CN104166003B (zh) * 2014-08-06 2016-06-08 中国人民解放军第二军医大学 人附睾蛋白4在制备系统性红斑狼疮性肾病诊断试剂或试剂盒中的应用
WO2016130802A1 (en) * 2015-02-11 2016-08-18 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2018113595A1 (en) * 2016-12-19 2018-06-28 Can Heal Biomeditech Corp. Synthetic polypeptide, composition comprising the same, antibody produced thereby, and uses thereof
CN121186383B (zh) * 2025-11-24 2026-03-13 华中科技大学 慢性肾病的蛋白质标志物的筛选及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016354A1 (en) * 1999-09-02 2001-03-08 Gene Logic, Inc. Modulation of he4 in inflammatory and renal diseases
CN1791797A (zh) * 2003-03-27 2006-06-21 儿童医院医疗中心 用于检测肾小管细胞损伤的早发的方法和试剂盒
US7588892B2 (en) * 2004-07-19 2009-09-15 Entelos, Inc. Reagent sets and gene signatures for renal tubule injury
US20070087387A1 (en) * 2005-04-21 2007-04-19 Prasad Devarajan Method for the Early Detection of Renal Disease Using Proteomics
US7842472B2 (en) * 2006-11-14 2010-11-30 Alere International Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
EP2121761A1 (en) * 2007-03-09 2009-11-25 Tripath Imaging, Inc. He4 monoclonal antibodies and methods for their use
EP2479571A3 (en) * 2007-03-26 2012-09-26 Novartis AG Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
CN101960308B (zh) * 2008-02-29 2014-07-09 国立大学法人名古屋大学 急性肾损伤及预后推测用生物标记物以及其用途
CN102016552A (zh) * 2008-03-05 2011-04-13 神谷来克斯公司 用于分子的高灵敏性检测的方法和组合物
AU2009254181A1 (en) * 2008-06-04 2009-12-10 Proteosys Ag Protein biomarkers for in vitro testing of developmental toxicity and embryotoxicity of chemical substances
JP2012501456A (ja) * 2008-08-28 2012-01-19 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法および組成物
EP2364370B1 (en) * 2008-11-22 2014-09-03 Astute Medical, Inc. Methods for prognosis of acute renal failure
MX342967B (es) * 2009-12-20 2016-10-19 Astute Medical Inc Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal.
US20120329071A1 (en) * 2010-03-05 2012-12-27 Mark Chance Protein biomarkers and therapeutic targets for renal disorders
CN103370619B (zh) * 2010-11-29 2016-01-20 美艾利尔圣地亚哥有限公司 诊断或风险预测心力衰竭的方法和试剂
EP2729181A4 (en) * 2011-07-06 2014-12-17 Alere San Diego Inc METHOD AND COMPOSITIONS FOR CALCULATING THE PROBABILITY OF PROGRESSION OF ACUTE CHILD LENGTH

Also Published As

Publication number Publication date
EP2729803A1 (en) 2014-05-14
EP2729803A4 (en) 2015-08-05
CN103858008A (zh) 2014-06-11
MX2014000283A (es) 2014-05-01
AU2012282918A1 (en) 2014-02-06
EA201490105A1 (ru) 2014-07-30
US20140171522A1 (en) 2014-06-19
JP2014521088A (ja) 2014-08-25
WO2013009573A1 (en) 2013-01-17
CN103858008B (zh) 2017-03-01
US20160097779A1 (en) 2016-04-07

Similar Documents

Publication Publication Date Title
US9784750B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2014207509B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2009285550B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20160097779A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2779902A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2661626B1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011097541A2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2773905A1 (en) Methods and composition for diagnosis and prognosis of renal injury and renal failure
AU2011213685B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2865559A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20190120858A1 (en) Methods for evaluating renal injury and renal failure using urine levels of chitinase-3-like protein 1
CA2880793A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2841335A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20130157297A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2988980A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2899658A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2014277715A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ706242B2 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20150168422A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20140363834A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20170705